Vergelijking
Enfuvirtid vs. Leuprorelin
Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.
Identiteit
Categorie
Onderzoek (overig)
Onderzoek (overig)
CAS-nr.
159519-65-0
53714-56-0
Molecuulmassa
4491.88 g/mol
1209.4 g/mol
Halfwaardetijd
geen gegevens
3 h
Sequentie
geen gegevens
Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEtWerkingsmechanisme
Enfuvirtid
Enfuvirtide binds the first heptad-repeat region (HR1) of the gp41 subunit of the HIV envelope protein. This prevents the conformational change required for fusion of the viral and cell membranes — the virus cannot enter the cell.
Leuprorelin
Leuprorelin is a GnRH-receptor agonist. After binding to pituitary GnRH receptors, it first causes a transient surge in luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release — the so-called flare. With continuous, non-pulsatile exposure the receptors are downregulated and desensitized, suppressing gonadotropin secretion and consequently lowering sex steroids (testosterone or estradiol) to low levels. This mechanism underlies the literature-described use in hormone-dependent conditions.
Bewijsbasis
Hoogste bewijs
Humane RCT
Humane RCT
Studies
1
4
waarvan bij mensen
1
4
Geregistreerde effecten
2
4
Openstaande tegenstrijdigheden
0
1
Gedocumenteerde bijwerkingen
1
3
Juridische status
Volledige vermeldingen
Frequently asked questions
- What is the difference between Enfuvirtid and Leuprorelin?
- Enfuvirtid is classified as "Onderzoek (overig)", while Leuprorelin is classified as "Onderzoek (overig)". Enfuvirtid: Enfuvirtide is a synthetic 36-amino-acid peptide and the first HIV-1 fusion inhibitor. It binds the HR1 region of the viral envelope protein gp41, blocking viral entry into the cell. Approved for treatment-experienced HIV patients. Leuprorelin: Leuprorelin (also leuprolide) is a synthetic nonapeptide analogue of gonadotropin-releasing hormone (GnRH/LHRH). It is an approved prescription medicine in several jurisdictions, including for advanced prostate cancer, endometriosis, uterine fibroids and central precocious puberty. This page neutrally summarizes the evidence base and legal status and is not a usage or dosing recommendation. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Enfuvirtid or Leuprorelin?
- The highest available evidence level is "Humane RCT" for Enfuvirtid and "Humane RCT" for Leuprorelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Enfuvirtid and Leuprorelin in Germany and the United States?
- Duitsland: Enfuvirtid — Op recept, Leuprorelin — Op recept. Verenigde Staten: Enfuvirtid — Op recept, Leuprorelin — Op recept. These are factual summaries with source and review date on the individual pages.